Drug therapy: Insulin analogues

被引:515
作者
Hirsch, IB [1 ]
机构
[1] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1056/NEJMra040832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:174 / 183
页数:10
相关论文
共 68 条
[41]   Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen [J].
Mohn, A ;
Strang, S ;
Wernicke-Panten, K ;
Lang, AM ;
Edge, JA ;
Dunger, DB .
DIABETES CARE, 2000, 23 (04) :557-559
[42]   Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin - absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects [J].
Mudaliar, SR ;
Lindberg, FA ;
Joyce, M ;
Beerdsen, P ;
Strange, P ;
Lin, A ;
Henry, RR .
DIABETES CARE, 1999, 22 (09) :1501-1506
[43]   Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men -: Comparison with NPH insulin and the influence of different subcutaneous injection sites [J].
Owens, DR ;
Coates, PA ;
Luzio, SD ;
Tinbergen, JP ;
Kurzhals, R .
DIABETES CARE, 2000, 23 (06) :813-819
[44]  
Pfutzner A, 1996, EXP CLIN ENDOCR DIAB, V104, P25
[45]   Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cell - The role of protein kinase C and NAD(P)H-oxidase activation [J].
Quagliaro, L ;
Piconi, L ;
Assaloni, R ;
Martinelli, L ;
Motz, E ;
Ceriello, A .
DIABETES, 2003, 52 (11) :2795-2804
[46]   A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes [J].
Raskin, P ;
Klaff, L ;
Bergenstal, R ;
Hallé, JP ;
Donley, D ;
Mecca, T .
DIABETES CARE, 2000, 23 (11) :1666-1671
[47]   A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump [J].
Raskin, P ;
Holcombe, JH ;
Tamborlane, WV ;
Malone, JI ;
Strowig, S ;
Ahern, JA ;
Lavent, F .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) :295-300
[48]   Optimal administration of lispro insulin in hyperglycemic type 1 diabetes [J].
Rassam, AG ;
Zeise, TM ;
Burge, MR ;
Schade, DS .
DIABETES CARE, 1999, 22 (01) :133-136
[49]   Less hypoglycemia with insulin glargine in intensive insulin therapy for the 1 diabetes [J].
Ratner, RE ;
Hirsch, IB ;
Neifing, JL ;
Garg, SK ;
Mecca, TE ;
Wilson, CA .
DIABETES CARE, 2000, 23 (05) :639-643
[50]   Use of insulin lispro in continuous subcutaneous insulin infusion treatment -: Results of a multicenter trial [J].
Renner, R ;
Pfútzner, A ;
Trautmann, M ;
Harzer, O ;
Sauter, K ;
Landgraf, R .
DIABETES CARE, 1999, 22 (05) :784-788